- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04525716
The Effect of the Covid-19 Pandemic Among Operated Patients
What Are the Effects of the Covid-19 Pandemic Among Operated Patients? A Hospital Based Cohort in Stockholm, Sweden
Study Overview
Status
Intervention / Treatment
Detailed Description
Background A novel Coronavirus (SARS-CoV-2) was first detected in the Hubei Province in China in December, 2019. The virus causes a severe respiratory disease (Coronavirus disease 2019, COVID-19) that has rapidly spread worldwide. The COVID-19 pandemic is prognosed to affect a majority of the world's population before the end of 2020. Throughout the course of the pandemic, patients will continuously need essential healthcare, such as for acute surgical conditions. How the clinical course and management of surgical conditions is influenced by concomitant COVID-19 is largely unknown. There is an acute need for an improved evidence base to inform treatment strategies and guide the management of this patient group.
Objectives of initial analyses
1. To compare confirmed COVID-19 patients with non-COVID-19 patients who undergo surgical treatment and study factors associated with good or bad outcomes.
Methods The study will enroll consecutive patients that undergo surgical treatment in the Stockholm Region. Data will be extracted from a series of linked electronic systems, such as electronic healthcare records systems, and regional data systems. Collected data will include routine clinical data, such as baseline characteristics, previous medical history, details on care given at the hospital and data from follow-up visits. Endpoints include death, length of hospital stay and complications, such as readmission, reoperation, sepsis, respiratory failure, and number of days in the intensive care unit. Outcome data of patients with confirmed COVID-19 will be compared to those of patients without COVID-19.
Dissemination and relevance To the best of the investigators knowledge, there has been no previous comprehensive comparative research on patients with and without confirmed COVID-19 that undergo surgical treatment. The results will be disseminated through peer-reviewed publications, aiming for journals with a rapid editorial process, preferably open access journals. The findings are expected to increase the knowledge to establish best-treatment strategies and improve outcomes, both for patients affected by COVID-19 and by future epidemics.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Andreas Älgå, MD, PhD
- Phone Number: 0702463287
- Email: andreas.alga@ki.se
Study Locations
-
-
-
Stockholm, Sweden
- Recruiting
- Samtliga akutsjukhus i Region Stockholm
-
Contact:
- Andreas Älgå, MD, PhD
- Phone Number: 0702463287
- Email: andreas.alga@ki.se
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients that undergo surgical treatment in the Stockholm Region during the study period
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
COVID-19
Patients with confirmed COVID-19 infection
|
We will compare patients with/without confirmed COVID-19 infection
|
Non-COVID-19
Patients without confirmed COVID-19 infection
|
We will compare patients with/without confirmed COVID-19 infection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Death
Time Frame: 30 days post surgery
|
Mortality
|
30 days post surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of stay
Time Frame: Through study completion, an average of 1 month
|
Length of hospital stay
|
Through study completion, an average of 1 month
|
Complications
Time Frame: 3 months post surgery
|
Includes readmission, reoperation, infection, sepsis, respiratory failure, and number of days in the intensive care unit
|
3 months post surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Gabriel Sandblom, MD, PhD, Södersjukhuset AB, Stockholm, Sweden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CovidKirurgi
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitätsspital ZürichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on COVID-19 infection status
-
University of AberdeenNot yet recruitingCovid19 | Pulmonary Embolism
-
Shiraz University of Medical SciencesCompletedCOVID-19 Pandemic | Dyspnea; Cardiac | Chest Syndrome | Functional Cardiac DisorderIran, Islamic Republic of
-
Centre integre universitaire de sante et de services...Université de MontréalCompletedCovid19 | Death | Elderly Infection | Infection Viral | Infections, Respiratory | Infection, Coronavirus | Old Age; Dementia | Epidemic DiseaseCanada
-
Salome KristensenTerminatedRheumatoid Arthritis | Systemic Lupus Erythematosus | Giant Cell Arteritis | Psoriatic Arthritis | Axial SpondyloarthritisDenmark
-
Centre Hospitalier Universitaire de NiceCompleted
-
Imperial College LondonWithdrawnInfertility, Male | Testosterone DeficiencyUnited Kingdom
-
University of ManitobaNatural Sciences and Engineering Research Council, Canada; ID Fusion Software... and other collaboratorsWithdrawn
-
NEAT ID FoundationGilead SciencesCompletedCOVID-19 | HIV-1-infectionSpain, Germany, Netherlands, United Kingdom, France, Belgium, Italy, Greece
-
Centre Hospitalier Intercommunal CreteilCompleted
-
PATHCompleted